Gan & Lee Pharmaceuticals announce positive Ph I results for insulin analog biosimilars

Jul 2, 2021

Gan & Lee Pharmaceuticals announced positive Ph I results for its three proposed insulin analog biosimilars (insulin aspart, insulin lispro and insulin glargine). Gan & Lee announced that all three Ph I studies met their primary PK and primary PD analyses.

Print Page Mail Article